MSB 6.07% $1.01 mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-108

  1. 3,027 Posts.
    lightbulb Created with Sketch. 235
    A very nice move this morning down. I don’t think a 12% rise will be enough to shake out the shorts. A blockbuster game changing event will need to happen to push this out. Today and already profit taking is the focus. The Novartis connection is an excellent addition to the mix. This is just what has been needed for a long long time. MSB now has a reliable rudder to keep it on course and attract the interest of the ‘big boys’.

    For the cynics, you know who you are, please note my sentiment which I changed a few days ago to buy and which I will retain. None, hold which I’ve preferred for a long time not necessary now. Hope now for an exciting time moving forward.

    Alhambra.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
-0.065(6.07%)
Mkt cap ! $1.147B
Open High Low Value Volume
$1.05 $1.05 99.5¢ $9.449M 9.298M

Buyers (Bids)

No. Vol. Price($)
2 64999 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.02 64541 3
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.